Categories News Press Releases Archives 2026 October September August July June May April March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May March February January 2023 December November October September August July June April January Jun 27 UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis Read More Jun 14 Recognizing Ethical Leadership at UCB Read More Jun 02 Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome Read More